# 2026-10253: DEA Bans Mysterious Ketamine Analog for Two Years

2026-10253, Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I, is a Federal Register rule from Justice Department, Drug Enforcement Administration published 2026-05-22, effective 2026-05-22; PRIA reads it as touching household money (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2026-10253
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-10253
- Title: Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
- Type: Rule
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 30204
- Published: 2026-05-22
- Effective: 2026-05-22
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-11

## In one line

DEA Bans Mysterious Ketamine Analog for Two Years

## Summary

Starting May 22, 2026, the DEA is putting 2-fluorodeschloroketamine (2-FDCK) into Schedule I, meaning it’s now treated like the most dangerous drugs. This affects anyone who makes, sells, or uses it, adding strict rules and serious penalties. The temporary ban lasts two years, giving the government time to decide if it should stay permanent.

## Abstract

The Drug Enforcement Administration (DEA) issues this temporary order to schedule 2-(2-fluorophenyl)-2- (methylamino)cyclohexan-1-one (commonly known as 2- fluorodeschloroketamine or 2-FDCK), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing 2-fluorodeschloroketamine in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle this substance.

## Effects PRIA read

- Immediate Schedule I Classification: cost, high. Starting May 22, 2026, 2-fluorodeschloroketamine (2-FDCK) is temporarily placed in Schedule I of the Controlled Substances Act until May 22, 2028 (with a possible one-year extension). This subjects 2-FDCK (including its salts and isomers) to the strictest federal controls because DEA found it poses…
- DEA Registration Required to Handle 2-FDCK: cost, high. As of May 22, 2026, anyone who handles (manufactures, distributes, imports/exports, researches, analyzes, or possesses) 2-FDCK must be registered with DEA under the Controlled Substances Act before continuing those activities. Persons currently handling 2-FDCK who are not registered must submit an…
- 90-Day Continuation for Certain Researchers: mixed, medium. If, on May 22, 2026, you are conducting research on 2-FDCK and are already registered to research another Schedule I substance, you may continue that research provided you submit a completed application or modification to register for 2-FDCK within 90 calendar days of May 22, 2026. You may continue…
- Immediate Compliance Steps for Current Registrants: cost, medium. Current DEA registrants who possess any quantity of 2-FDCK must take an inventory on the effective date and will have 30 calendar days from May 22, 2026 to comply with labeling, packaging, recordkeeping, and record submission requirements. After the initial inventory, registrants must inventory con…
- Manufacture, Import, and Quota Limits: cost, high. Only DEA-registered manufacturers may produce 2-FDCK and only within quotas assigned by DEA under the CSA as of May 22, 2026. All importation and exportation must comply with DEA import/export regulations and order form requirements apply to distributors.
- Surrender Stocks or Cease Handling: cost, high. If you do not want or cannot obtain a Schedule I registration for 2-FDCK, you must surrender all quantities of the substance; continuing to possess or handle any quantity without authorization is unlawful as of May 22, 2026.
- Unauthorized Handling: Criminal & Civil Risk: cost, high. Any handling of 2-FDCK that is not authorized under the CSA on or after May 22, 2026 is unlawful and may subject the person to administrative, civil, and criminal sanctions under federal law.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-10253 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/22/2026-10253/schedules-of-controlled-substances-temporary-placement-of-2-fluorodeschloroketamine-in-schedule-i)
- [2026-10253 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-22/pdf/2026-10253.pdf)

## Related
- [Previous: 2026-10202, Kentucky Regulatory Program](https://policyrisk.com/federal-register/2026-10202)
- [Next: 2026-10258, Rescinding Portions of Department of the Interior Title VI Regulations To Confo…](https://policyrisk.com/federal-register/2026-10258)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-10253 (as of 2026-06-11).
